NCT03159819View on ClinicalTrials.gov

Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma

NAUnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2021

Conditions
Advanced Gastric AdenocarcinomaPancreatic Adenocarcinoma
Interventions
GENETIC

CAR-CLD18 T Cells

Dose escalation will be applied in this study.

Trial Locations (1)

200433

RECRUITING

Changhai Hospital, Shanghai

Sponsors
All Listed Sponsors
collaborator

CARsgen Therapeutics Co., Ltd.

INDUSTRY

lead

Changhai Hospital

OTHER

NCT03159819 - Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter